Cite
C-X-C chemokine receptor 2 correlates with unfavorable prognosis and facilitates malignant cell activities via activating JAK2/STAT3 pathway in non-small cell lung cancer.
MLA
Wei, Lin, et al. “C-X-C Chemokine Receptor 2 Correlates with Unfavorable Prognosis and Facilitates Malignant Cell Activities via Activating JAK2/STAT3 Pathway in Non-Small Cell Lung Cancer.” Cell Cycle, vol. 18, no. 24, Dec. 2019, pp. 3456–71. EBSCOhost, https://doi.org/10.1080/15384101.2019.1689471.
APA
Wei, L., Liu, Y., Ma, Y., Ding, C., Zhang, H., Lu, Z., Gu, Z., & Zhu, C. (2019). C-X-C chemokine receptor 2 correlates with unfavorable prognosis and facilitates malignant cell activities via activating JAK2/STAT3 pathway in non-small cell lung cancer. Cell Cycle, 18(24), 3456–3471. https://doi.org/10.1080/15384101.2019.1689471
Chicago
Wei, Lin, Yugang Liu, Yuefeng Ma, Chao Ding, Huijun Zhang, Zhenghui Lu, Zhenning Gu, and Changsheng Zhu. 2019. “C-X-C Chemokine Receptor 2 Correlates with Unfavorable Prognosis and Facilitates Malignant Cell Activities via Activating JAK2/STAT3 Pathway in Non-Small Cell Lung Cancer.” Cell Cycle 18 (24): 3456–71. doi:10.1080/15384101.2019.1689471.